NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies total assets
Total assets on the balance sheet at the end of each period.
Neuroone Medical Technologies's total assets was $6.19M at Jun 30, 2026. For fiscal 2025 it was $10.79M, up 100.9% from the year before. Over ten years it grew 169.9% a year on average. The highest annual figure on record is $12.82M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $10.79M | +100.9% |
| FY2024 | Sep 30, 2024 | $5.37M | -33.7% |
| FY2023 | Sep 30, 2023 | $8.10M | -36.9% |
| FY2022 | Sep 30, 2022 | $12.82M | +61.5% |
| FY2021 | Sep 30, 2021 | $7.94M | +66.8% |
| FY2020 | Sep 30, 2020 | $4.76M | +1804.0% |
| FY2017 | Dec 31, 2017 | $249.99K | -67.0% |
| FY2016 | Dec 31, 2016 | $756.93K | +41082.3% |
| FY2015 | Dec 31, 2015 | $1.84K | +796.6% |
| FY2014 | Dec 31, 2014 | $205 | -61.0% |
| FY2013 | Dec 31, 2013 | $525 | -53.0% |
| FY2012 | Dec 31, 2012 | $1.12K | -91.9% |
| FY2011 | Dec 31, 2011 | $13.85K | +51.7% |
| FY2010 | Dec 31, 2010 | $9.13K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $6.19M | -42.8% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $7.57M | +69.8% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $8.58M | +32.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $10.79M | +100.9% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $10.82M | +120.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $4.46M | -17.4% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $6.49M | +11.5% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $5.37M | -33.7% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $4.91M | -14.7% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $5.39M | -25.1% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $5.82M | -39.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $8.10M | -36.9% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $5.76M | -50.2% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $7.21M | -48.9% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $9.66M | -43.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $12.82M | +61.5% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $11.57M | +18.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $14.09M | +18.2% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $17.18M | +117.2% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $7.94M | +66.8% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $9.81M | +119.8% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $11.92M | +757.8% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $7.91M | +197.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.76M | +1804.0% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $4.46M | +1566.3% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $1.39M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $2.66M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $249.99K | -67.0% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $267.81K | +6161.7% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $0 | -100.0% |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $0 | -100.0% |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $756.93K | +41082.3% |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | $4.28K | +2027.9% |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | $4.28K | +1052.8% |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | $1.82K | +831.3% |
| Q4 FY2015CQ4 2015 | Dec 31, 2015 | $1.84K | +796.6% |
| Q3 FY2015CQ3 2015 | Sep 30, 2015 | $201 | – |
| Q2 FY2015CQ2 2015 | Jun 30, 2015 | $371 | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | $195 | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | $205 | – |
See a number that looks wrong?